IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 72 filers reported holding IMMUNE DESIGN CORP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $390,000 | – | 100,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 1,236,394 | $4,080,000 | 4.69% |
| Versant Venture Management, LLC | 2,208,210 | $7,287,093,000 | 2.33% |
| EcoR1 Capital, LLC | 4,437,600 | $14,422,000 | 1.45% |
| BVF INC/IL | 4,106,200 | $13,550,000 | 1.37% |
| Abingworth LLP | 352,300 | $1,145,000 | 0.71% |
| DAFNA Capital Management LLC | 328,500 | $1,084,000 | 0.53% |
| Bain Capital Public Equity Management, LLC | 1,680,987 | $5,547,000 | 0.40% |
| Telemetry Investments, L.L.C. | 248,800 | $821,000 | 0.31% |
| Stonepine Capital Management, LLC | 161,226 | $532,000 | 0.28% |
| Focused Wealth Management, Inc | 12,395 | $41,000 | 0.01% |